CPMP recommends expansion of desloratadine indication to indoor and outdoor allergies March 8, 2002 No Comments
Cypress initiates phase II program for milnacipran in fibromyalgia syndrome Feb. 26, 2002 No Comments
FDA approves Zometa for bone metastases from solid tumors and multiple myeloma Feb. 26, 2002 No Comments
RSS